Robert E. Mosser

Array ( [id] => 6196764 [patent_doc_number] => 20110028522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'FULLERENE THERAPIES FOR INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/921049 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7361 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028522.pdf [firstpage_image] =>[orig_patent_app_number] => 12921049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113164 [patent_doc_number] => 20110190251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHOD FOR INHIBITING THE BUILD-UP OF ARTERIAL PLAQUE BY ADMINISTERING FULLERENES' [patent_app_type] => utility [patent_app_number] => 12/921083 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8773 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190251.pdf [firstpage_image] =>[orig_patent_app_number] => 12921083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385273 [patent_doc_number] => 20090226518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => '(MONITORING ONLY) COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPELIPIDEMIA ONCE A DAY AT NIGHT' [patent_app_type] => utility [patent_app_number] => 12/394441 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18881 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226518.pdf [firstpage_image] =>[orig_patent_app_number] => 12394441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355992 [patent_doc_number] => 20100022527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'BIPHENYL SUBSTITUTED SPIROTETRONIC ACIDS AND THEIR USE FOR THE TREATMENT OF RETROVIRAL DISEASES' [patent_app_type] => utility [patent_app_number] => 12/392844 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23753 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022527.pdf [firstpage_image] =>[orig_patent_app_number] => 12392844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055777 [patent_doc_number] => 20110112137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'HIV PROTEASE INHIBITOR AND CYTOCHROME P450 INHIBITOR COMBINATIONS' [patent_app_type] => utility [patent_app_number] => 12/919011 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16856 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112137.pdf [firstpage_image] =>[orig_patent_app_number] => 12919011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392234 [patent_doc_number] => 20090209547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'C-8 HALOGENATED MACROLIDES' [patent_app_type] => utility [patent_app_number] => 12/370805 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13879 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209547.pdf [firstpage_image] =>[orig_patent_app_number] => 12370805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422076 [patent_doc_number] => 20090148531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'RATE-CONTROLLED PARTICLES' [patent_app_type] => utility [patent_app_number] => 12/368884 [patent_app_country] => US [patent_app_date] => 2009-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4823 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148531.pdf [firstpage_image] =>[orig_patent_app_number] => 12368884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6348869 [patent_doc_number] => 20100021494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'HEPATITIS-RELATED PREVENTIVE OR THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/366966 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5701 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021494.pdf [firstpage_image] =>[orig_patent_app_number] => 12366966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458717 [patent_doc_number] => 20090258869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'METHODS AND COMPOUNDS FOR TREATMENT OR PREVENTION OF SUBSTANCE-RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/367412 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25325 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258869.pdf [firstpage_image] =>[orig_patent_app_number] => 12367412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026573 [patent_doc_number] => 20110054034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'METHODS OF USING CARBOXYLIC AMIDES AS ANTIMICROBIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 12/866408 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14839 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054034.pdf [firstpage_image] =>[orig_patent_app_number] => 12866408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352876 [patent_doc_number] => 20100331410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Biaryl Amides' [patent_app_type] => utility [patent_app_number] => 12/865321 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7223 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331410.pdf [firstpage_image] =>[orig_patent_app_number] => 12865321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6098144 [patent_doc_number] => 20110003889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'MEMBRANE FUSION INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/865360 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14528 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003889.pdf [firstpage_image] =>[orig_patent_app_number] => 12865360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687541 [patent_doc_number] => 20090176750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Compositions and methods for enhancing corticosteroid delivery' [patent_app_type] => utility [patent_app_number] => 12/322346 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2980 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176750.pdf [firstpage_image] =>[orig_patent_app_number] => 12322346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687541 [patent_doc_number] => 20090176750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Compositions and methods for enhancing corticosteroid delivery' [patent_app_type] => utility [patent_app_number] => 12/322346 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2980 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176750.pdf [firstpage_image] =>[orig_patent_app_number] => 12322346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386379 [patent_doc_number] => 20090227624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Oxazole and thiazole compounds as beta-catenin modulators and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/322070 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31216 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 55 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227624.pdf [firstpage_image] =>[orig_patent_app_number] => 12322070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316536 [patent_doc_number] => 20090281134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'USE OF IBOGAMINE CONGENERS FOR TREATING OBESITY' [patent_app_type] => utility [patent_app_number] => 12/360434 [patent_app_country] => US [patent_app_date] => 2009-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12311 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281134.pdf [firstpage_image] =>[orig_patent_app_number] => 12360434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316599 [patent_doc_number] => 20090281197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Acetic Acid/Thymol Compositions and Their Use in the Treatment of Onychomycosis' [patent_app_type] => utility [patent_app_number] => 12/358474 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3815 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281197.pdf [firstpage_image] =>[orig_patent_app_number] => 12358474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149869 [patent_doc_number] => 20110021464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'METHODS OF TREATING VIRAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/864431 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14957 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021464.pdf [firstpage_image] =>[orig_patent_app_number] => 12864431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682195 [patent_doc_number] => 20100022613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Compounds Having CRTH2 Antagonist Activity' [patent_app_type] => utility [patent_app_number] => 12/357792 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12520 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022613.pdf [firstpage_image] =>[orig_patent_app_number] => 12357792 [rel_patent_id] =>[rel_patent_doc_number] =>)